Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
- - - - - - - 630M
0.61%0.67%34.02x20.24x11.84x24.88x25.86x 995B
2.11%2.21%28.36x6.88x6.26x17.51x19.57x 614B
2.84%2.96%31.72x886.55x7.19x14.9x15.26x 431B
2.79%2.86%19.93x7.13x4.73x11.72x13x 353B
2.84%2.97%21.85x6.15x5.66x14.11x14.95x 293B
2.11%2.23%20.2x4.54x4.19x11.86x12.58x 245B
2.59%2.73%25.61x19.68x6.68x11.78x15.29x 210B
3.7%3.6%13.52x5.86x5.15x10.43x12.82x 210B
2.44%2.52%-48.74x8.55x5.83x32.22x59.8x 168B
6.77%6.84%13.25x1.59x3.14x7.99x8.98x 145B
3.84%3.9%11.74x5.53x3.28x8.58x9.23x 135B
-.--%-.--%28.26x5.29x8.12x18.29x19.25x 121B
3.63%3.82%13.22x4.57x2.81x8.17x9.25x 103B
5.7%6.05%12.16x1.2x2.12x6.81x7.6x 103B
2.05%2.35%21.64x4.89x7.25x13.76x14.4x 69.76B
0.28%1.24%20.42x1.7x1.67x7.9x13.27x 54.59B
3.87%3.96%42.44x1.13x2.65x9.2x27.92x 53.57B
0.49%0.57%38.37x5.12x8.76x29.22x31.98x 52.24B
Average 2.7% 2.86% 19.33x 55.37x 5.41x 14.41x 18.39x 229.24B
Weighted average by Cap. 2.3% 2.41% 22.91x 96.79x 6.92x 16.68x 19.25x
Other Pharmaceuticals